MorphoSys and Novartis Sign Antibody Agreement
By Business Review Editor
Pharma Deals Review: Vol 2004 Issue 49 (Table of Contents)
Published: 4 Jul-2004
DOI: 10.3833/pdr.v2004.i49.797 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
MorphoSys formed a 3-year strategic alliance with Novartis to discover and develop antibody-based therapeutics for a variety of diseases...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS